TrialGut microbes2019

Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome.

Anthony A Fodor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.